14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $26.98 $26.98 Thursday, 8th Jun 2023 MYOV stock ended at $26.98. During the day the stock fluctuated 0% from a day low at $26.98 to a day high of $26.98.
90 days $26.98 $26.98
52 weeks $9.81 $27.06

Historical Myovant Sciences Ltd prices

Date Open High Low Close Volume
Dec 07, 2022 $26.82 $26.91 $26.82 $26.85 419 171
Dec 06, 2022 $26.82 $26.90 $26.81 $26.90 370 938
Dec 05, 2022 $26.82 $26.87 $26.79 $26.81 441 265
Dec 02, 2022 $26.74 $26.93 $26.73 $26.91 403 383
Dec 01, 2022 $26.83 $26.83 $26.71 $26.77 375 244
Nov 30, 2022 $26.80 $26.86 $26.76 $26.86 835 343
Nov 29, 2022 $26.80 $26.81 $26.76 $26.76 255 484
Nov 28, 2022 $26.80 $26.84 $26.79 $26.80 520 165
Nov 25, 2022 $26.82 $26.85 $26.78 $26.78 189 993
Nov 23, 2022 $26.82 $26.90 $26.79 $26.87 326 288
Nov 22, 2022 $26.76 $26.80 $26.74 $26.79 379 076
Nov 21, 2022 $26.76 $26.78 $26.75 $26.78 152 946
Nov 18, 2022 $26.78 $26.78 $26.74 $26.76 1 157
Nov 17, 2022 $26.73 $26.79 $26.73 $26.79 398 645
Nov 16, 2022 $26.73 $26.77 $26.73 $26.76 321 749
Nov 15, 2022 $26.74 $26.78 $26.72 $26.77 1 073 281
Nov 14, 2022 $26.70 $26.76 $26.70 $26.76 2 733 892
Nov 11, 2022 $26.71 $26.73 $26.68 $26.70 685 127
Nov 10, 2022 $26.72 $26.74 $26.70 $26.73 646 062
Nov 09, 2022 $26.72 $26.72 $26.67 $26.71 723 638
Nov 08, 2022 $26.69 $26.73 $26.68 $26.71 658 008
Nov 07, 2022 $26.68 $26.72 $26.65 $26.68 1 733 389
Nov 04, 2022 $26.78 $26.78 $26.65 $26.65 3 051 141
Nov 03, 2022 $26.73 $26.75 $26.71 $26.71 1 714 927
Nov 02, 2022 $26.74 $26.78 $26.72 $26.75 3 174 360
Click to get the best stock tips daily for free!

About Myovant Sciences Ltd

Myovant Sciences Ltd Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, whic... MYOV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT